Skip to main content

Andrew Kruse

NIH Rank #1472
  • R01 Holder
  • Translational
  • Top 10% Funded
  • Multi-Institutional
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10334335Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Microbiology & Immunology
  • CHEMISTRY
  • Biochemistry

NIH Funding · FY2025

Linked Award Amount
$4.8M
Full award amounts, FY2025
Award Records
7
Records listing this PI
Award-Linked Rank
#1,472
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Andrew Kruse. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Andrew Kruse as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI164647-04R01
    Molecular basis of spore germination
    $847.2K
    award amount
  • 1R01AI187556-01R01
    Bactericidal antibiotics targeting lipoprotein transport in Gram-negative bacteria
    $749.4K
    award amount
  • 5U19AI158028-04U19
    Exploiting membrane targets to overcome antibiotic resistance
    $737K
    award amount
  • 5R01NS131463-02R01
    Mechanisms of Regulation of Neuronal GPCRs by KCTDs
    $646.1K
    award amount
  • 1R01AI187524-01R01
    Structure and dynamics of bacterial cell wall synthases
    $637.7K
    award amount
  • 5R01AR081264-04R01
    The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation
    $629.6K
    award amount
  • 5R01AR079489-04R01
    Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder
    $601.7K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Andrew Kruse as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Harvard Medical School
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #856
  7. 2024
    Entered Top 25% Nationally
    Ranked #856
  8. 2024
    Entered Top 10% Nationally
    Ranked #856
  9. 2024
    Entered Top 5% Nationally
    Ranked #856
  10. 2025
    $10M Cumulative Funding
  11. 2025
    Multi-Institutional Research
    Awards at 4 institutions
  12. 2025
    R01 Grant Holder